BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 17694476)

  • 1. Chronic paranoid psychosis and dementia following interferon-alpha treatment of hepatitis C: a case report.
    Drozdz W; Borkowska A; Wilkosc M; Halota W; Dybowska D; Rybakowski JK
    Pharmacopsychiatry; 2007 Jul; 40(4):146-8. PubMed ID: 17694476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Major depressive disorder with psychotic features induced by interferon-alpha treatment for hepatitis C in a polydrug abuser.
    Kalyoncu OA; Tan D; Mirsal H; Pektas O; Beyazyurek M
    J Psychopharmacol; 2005 Jan; 19(1):102-5. PubMed ID: 15671136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychosis in a methadone-substituted patient during interferon-alpha treatment of hepatitis C.
    Schäfer M; Boetsch T; Laakmann G
    Addiction; 2000 Jul; 95(7):1101-4. PubMed ID: 10962774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paranoid psychosis and cognitive impairment associated with hepatitis C antiviral therapy.
    Budhram A; Cebrian C
    Gen Hosp Psychiatry; 2014; 36(1):126.e3-5. PubMed ID: 24210465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuropsychiatric side effects of HCV therapy and their treatment: focus on IFN alpha-induced depression.
    Hauser P
    Gastroenterol Clin North Am; 2004 Mar; 33(1 Suppl):S35-50. PubMed ID: 15081102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Side effects of alpha interferon in chronic hepatitis C.
    Dusheiko G
    Hepatology; 1997 Sep; 26(3 Suppl 1):112S-121S. PubMed ID: 9305675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hypothyroidism as a complication of the treatment of hepatitis C with interferon].
    Gomollón García F; Simón Marco MA; Vela J; García López S; Fuentes Olmo J
    An Med Interna; 1996 Sep; 13(9):438-40. PubMed ID: 9132035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ophthalmologic side effects during alpha-interferon therapy for viral hepatitis.
    d'Alteroche L; Majzoub S; Lecuyer AI; Delplace MP; Bacq Y
    J Hepatol; 2006 Jan; 44(1):56-61. PubMed ID: 16223542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Peripheral neuropathy during a second cycle of treatment with high doses of interferon-alpha in a patient with hepatitis C, and a review of the literature].
    Téllez-Zenteno JF; Negrete-Pulido O; Nuñez M; Estañol-Vidal B; García-Ramos G
    Rev Neurol; 2002 Oct 1-15; 35(7):644-6. PubMed ID: 12389150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Alpha interferon-induced eczema in atopic patients infected by hepatitis C virus: 4 case reports].
    Berger L; Descamps V; Marck Y; Dehen L; Grossin M; Crickx B; Marcellin P; Belaich S
    Ann Dermatol Venereol; 2000 Jan; 127(1):51-5. PubMed ID: 10717563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interferon-induced psychosis as a "psychiatric contraindication" to hepatitis C treatment: a review and case-based discussion.
    Silverman BC; Kim AY; Freudenreich O
    Psychosomatics; 2010; 51(1):1-7. PubMed ID: 20118434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interferon-alpha associated arthritis.
    Chung A; Older SA
    J Rheumatol; 1997 Sep; 24(9):1844-5. PubMed ID: 9292816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Depression during therapy with interferon alpha--how long should an antidepressant treatment last?
    Nickel T; Sonntag A; Backmund M; Pollmächer T
    Pharmacopsychiatry; 2005 Mar; 38(2):102-4. PubMed ID: 15744637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Interferon-induced paranoid psychosis. Review of the literature and case report].
    Kornischka J; Burtscheidt W; Gaebel W
    Nervenarzt; 2002 May; 73(5):463-7. PubMed ID: 12078026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Life-threatening severe immune thrombocytopenia during alpha-interferon therapy for chronic hepatitis C.
    Fujii H; Kitada T; Yamada T; Sakaguchi H; Seki S; Hino M
    Hepatogastroenterology; 2003; 50(51):841-2. PubMed ID: 12828100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Neuropsychiatric symptoms related to interferon alpha].
    Małyszczak K; Inglot M; Pawłowski T; Czarnecki M; Rymer W; Kiejna A
    Psychiatr Pol; 2006; 40(4):787-97. PubMed ID: 17068950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generalized lichen nitidus with involvement of the palms following interferon alpha treatment.
    Scheler M; Proelss J; Bräuninger W; Bieber T; Wenzel J
    Dermatology; 2007; 215(3):236-9. PubMed ID: 17823522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Psychotic disorders induced by interferon alfa].
    D'Innella P; Zaccala G; Terazzi M; Olgiati P; Torre E
    Recenti Prog Med; 2002 Jun; 93(6):367-9. PubMed ID: 12085716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rheumatoid arthritis: a complication of interferon therapy.
    Nadir F; Fagiuoli S; Wright HI; Nadir A; Hopp E; Gavaler J; Van Thiel DH
    J Okla State Med Assoc; 1994 May; 87(5):228-30. PubMed ID: 8051581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Severe exacerbation of hepatitis C-associated vasculitic neuropathy following treatment with interferon alpha: a case report and literature review.
    Boonyapisit K; Katirji B
    Muscle Nerve; 2002 Jun; 25(6):909-13. PubMed ID: 12115983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.